[1]
“The use of nootropics in Alzheimer’s disease: is there light at the end of the tunnel?”, Biomed. Res. Ther., vol. 6, no. 1, pp. 2937–2944, Jan. 2019, doi: 10.15419/bmrat.v6i1.513.